title: [Prevention of progression in nephropathies].
abstract: Intermittent dialysis is excessively expensive and pretentious psychologically and socially. As a result the research is concentrated on the prevention of kidney disease progression. Preventive measures: a) Protein restriction forms the basis of nonpharmacologic measures. b) Consequent antihypertensive therapy, with the aim to decrease blood pressure < 17.5/11.25 kPa (140/90 Torr), is the most effective prevention. The basic drugs are ACEI eventually in combination with Ca antagonists. They even reverse kidney disease progression in early phases. c) Antiaggregation therapy prevents the formation of fibrin deposits in glomeruli and the thrombogenesis. d) Insulin resistance correction prevents the development of glomerulosclerosis and atherosclerosis. e) Antihyperlipemic therapy is required only in a small number of patients. f) Correction of mineral balance prevents or corrects osteodystrophy. These measures could decrease kidney disease progression and the entrance of patients into intermittent dialysis by 10-20% and a further decrease to 50% is expected to be reached until the year 2000. (Fig. 3, Tab. 3, Ref. 43.).
authors: Klinika farmakoterapie a Ustav preventívnej a klinickej medicíny v Bratislave, Slovakia.
authors: R
authors: R
authors: Dzúrik
authors: V
authors: V
authors: Dzúriková
authors: A
authors: A
authors: Oksa
authors: V
authors: V
authors: Fedelesová
authors: M
authors: M
authors: Gajdos
authors: V
authors: V
authors: Spustová
mesh_terms: D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism / Q000628:therapy*
vernacular_title: Prevencia progresie nefropatií.